BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 32115698)

  • 21. Identification of a missense mutation in the tyrosinase gene in a Chinese family with oculocutaneous albinism type 1.
    Lu Q; Yuan L; Xu H; Huang X; Yang Z; Yi J; Ni B; Chen Y; Deng H
    Mol Med Rep; 2017 Mar; 15(3):1426-1430. PubMed ID: 28112372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of 53 novel DNA variations within the tyrosinase gene and accumulation of mutations in 17 patients with albinism.
    Opitz S; Käsmann-Kellner B; Kaufmann M; Schwinger E; Zühlke C
    Hum Mutat; 2004 Jun; 23(6):630-1. PubMed ID: 15146472
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel missense mutation of the TYR gene in a pedigree with oculocutaneous albinism type 1 from China.
    Lin YY; Wei AH; Zhou ZY; Zhu W; He X; Lian S
    Chin Med J (Engl); 2011 Oct; 124(20):3358-61. PubMed ID: 22088535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comprehensive analysis reveals mutational spectra and common alleles in Chinese patients with oculocutaneous albinism.
    Wei A; Wang Y; Long Y; Wang Y; Guo X; Zhou Z; Zhu W; Liu J; Bian X; Lian S; Li W
    J Invest Dermatol; 2010 Mar; 130(3):716-24. PubMed ID: 19865097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sequence analysis of tyrosinase gene in ocular and oculocutaneous albinism patients: introducing three novel mutations.
    Khordadpoor-Deilamani F; Akbari MT; Karimipoor M; Javadi G
    Mol Vis; 2015; 21():730-5. PubMed ID: 26167114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of a novel mutation (p.Ile198Thr) in gene TYR in a Pakistani family with nonsyndromic oculocutaneous albinism.
    Shah SA; Din SU; Raheem N; Daud S; Mubeen J; Nadeem A; Tayyab M; Baloch DM; Babar ME; Ahmad J
    Clin Exp Dermatol; 2014 Jul; 39(5):646-8. PubMed ID: 24934919
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic Causes of Oculocutaneous Albinism in Pakistani Population.
    Sajid Z; Yousaf S; Waryah YM; Mughal TA; Kausar T; Shahzad M; Rao AR; Abbasi AA; Shaikh RS; Waryah AM; Riazuddin S; Ahmed ZM
    Genes (Basel); 2021 Mar; 12(4):. PubMed ID: 33800529
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional assessment of tyrosinase variants identified in individuals with albinism is essential for unequivocal determination of genotype-to-phenotype correlation.
    Mondal M; Sengupta M; Ray K
    Br J Dermatol; 2016 Dec; 175(6):1232-1242. PubMed ID: 27537549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of a functionally significant tri-allelic genotype in the Tyrosinase gene (TYR) causing hypomorphic oculocutaneous albinism (OCA1B).
    Norman CS; O'Gorman L; Gibson J; Pengelly RJ; Baralle D; Ratnayaka JA; Griffiths H; Rose-Zerilli M; Ranger M; Bunyan D; Lee H; Page R; Newall T; Shawkat F; Mattocks C; Ward D; Ennis S; Self JE
    Sci Rep; 2017 Jun; 7(1):4415. PubMed ID: 28667292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic studies of multiple consanguineous Pakistani families segregating oculocutaneous albinism identified novel and reported mutations.
    Gul H; Shah AH; Harripaul R; Mikhailov A; Prajapati K; Khan E; Ullah F; Zubair M; Ali MZ; Shah AH; Salman S; Khan S; Vincent JB; Khan MA
    Ann Hum Genet; 2019 Jul; 83(4):278-284. PubMed ID: 30868578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel deletion of exon 3 in TYR gene causing Oculocutaneous albinism 1B in an Indian family along with intellectual disability associated with chromosomal copy number variations.
    Dhangar S; Panchal P; Ghatanatti J; Suralkar J; Shah A; Vundinti BR
    BMC Med Genomics; 2022 Jan; 15(1):2. PubMed ID: 34980106
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tyrosinase gene mutations in oculocutaneous albinism 1 (OCA1): definition of the phenotype.
    King RA; Pietsch J; Fryer JP; Savage S; Brott MJ; Russell-Eggitt I; Summers CG; Oetting WS
    Hum Genet; 2003 Nov; 113(6):502-13. PubMed ID: 13680365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutational Analysis of TYR, OCA2, and SLC45A2 Genes in Chinese Families with Oculocutaneous Albinism.
    Lin Y; Chen X; Yang Y; Che F; Zhang S; Yuan L; Wu Y
    Mol Genet Genomic Med; 2019 Jul; 7(7):e00687. PubMed ID: 31199599
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutations of the tyrosinase gene in Indo-Pakistani patients with type I (tyrosinase-deficient) oculocutaneous albinism (OCA).
    Tripathi RK; Bundey S; Musarella MA; Droetto S; Strunk KM; Holmes SA; Spritz RA
    Am J Hum Genet; 1993 Dec; 53(6):1173-9. PubMed ID: 7902671
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TYR mutation in a Chinese population with oculocutaneous albinism: Molecular characteristics and ophthalmic manifestations.
    Chen C; Li J; Wang B; Wang Y; Yu X
    Exp Eye Res; 2024 Feb; 239():109761. PubMed ID: 38145795
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Genetics of oculocutaneous albinism].
    Zühlke C; Stell A; Käsmann-Kellner B
    Ophthalmologe; 2007 Aug; 104(8):674-80. PubMed ID: 17646993
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Electron microscopic DOPA reaction test for oculocutaneous albinism.
    Takizawa Y; Kato S; Matsunaga J; Aozaki R; Tomita Y; Nishikawa T; Shimizu H
    Arch Dermatol Res; 2000 Jun; 292(6):301-5. PubMed ID: 10929771
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tyrosinase gene analysis in Japanese patients with oculocutaneous albinism.
    Goto M; Sato-Matsumura KC; Sawamura D; Yokota K; Nakamura H; Shimizu H
    J Dermatol Sci; 2004 Sep; 35(3):215-20. PubMed ID: 15381243
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification and characterization of two novel noncoding tyrosinase (TYR) gene variants leading to oculocutaneous albinism type 1.
    Li C; Chen Q; Wu J; Ren J; Zhang M; Wang H; Li J; Tang Y
    J Biol Chem; 2022 May; 298(5):101922. PubMed ID: 35413289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutation spectrum of the TYR and SLC45A2 genes in patients with oculocutaneous albinism.
    Ko JM; Yang JA; Jeong SY; Kim HJ
    Mol Med Rep; 2012 Apr; 5(4):943-8. PubMed ID: 22294196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.